Search clinical trials for: N-acetylcysteine (NAC) 600 mg

Total 3745 results

Tehran University of Medical Sciences

Unknown

Effect of N-acetylcystein in Myocardial Infarction

Acute Myocardial Infarction

Iran, Islamic Republic of
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers

Asthma; Allergic Rhinitis

China
JMackem Co., Ltd
Seoul National University Hospital

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Diabetic Neuropathies | Neuropathic Pain | Post Herpetic Neuralgia

Korea, Republic of
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); American Academy of Child Adolescent...

Completed

An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents (NAC MJ Pilot)

Cannabis Dependence

United States
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Influenza A

China
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

MELAS Syndrome | Mitochondrial Respiratory Chain Deficiencies

Korea, Republic of
Pfizer

Withdrawn

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Ulcerative Colitis

United States
Zambon SpA

Completed

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Respiratory Tract Diseases | Abnormal Mucus Secretions

China
Royal Alexandra Hospital
University of Alberta; Gambro Renal Products, Inc.

Completed

Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis

Rhabdomyolysis

Canada, Saudi Arabia
Ilkos Therapeutic Inc.

Completed

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Venous Leg Ulcer

Spain, Hungary, Canada, United States, Brazil, Argentina, Austria, Czechia, Italy, Poland, Slovakia
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
VA Office of Research and Development
National Center for Complementary and Integrative Health (NCCIH)

Completed

N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy (CGDN)

Diabetic Nephropathy | Proteinuria | Oxidative Stress

United States
NeuroBo Pharmaceuticals Inc.

Completed

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Hypercholesterolemia | Hypertriglyceridemia
Cambridge Health Alliance

Completed

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

COVID | Oxidative Stress | Sars-CoV2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

United States
Medical University of South Carolina

Completed

A Pilot Trial to Determine the Effective N-acetylcysteine Dose for Opioid Reduction for Spine Surgery.

Surgery

United States
University of California, San Francisco

Terminated

Clinical Trial of NAC in Asthma (CONA)

Asthma

United States
Janssen Research & Development, LLC

Completed

A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants

Healthy

United States
Assiut University

Not yet recruiting

NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major

Thalassemia Major
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary

United States
Children's Hospital Los Angeles

Completed

NAC to Prevent Cisplatin-induced Hearing Loss

Neuroectodermal Tumors, Primitive | Liver Neoplasms | Osteosarcoma | Other Childhood Cancers Using Cisplatin-based Regimens

United States
University of Notre Dame Australia

Unknown

Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study. (MIGRANT)

Migraine, Headaches
Tibotec Pharmaceuticals, Ireland

Withdrawn

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

HIV Infections

Netherlands
Lexicon Pharmaceuticals

Completed

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

N-acetylcysteine for Tobacco Use Disorder

Smoking | Nicotine Dependence

United States
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

Early Rheumatoid Arthritis

China
Indiana University
BioAdvantex Pharma

Completed

N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults

HIV | Endothelial Dysfunction | Oxidative Stress

United States
Kevin Gray, MD

Completed

Use of N-Acetylcysteine (NAC) in Fingernail Biting

Onychophagia

United States
Federal University of Rio Grande do Sul
Hospital de Clinicas de Porto Alegre; Programa de pós-graduação em endocrinologia

Completed

Effects of N-acetylcysteine on Low T3 Syndrome

Ischemic Heart Disease | Acute Myocardial Infarction | Euthyroid Sick Syndrome

Brazil
Wake Forest University
Zambon SpA

Completed

Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

Chronic Bronchitis

United States
Ascentage Pharma Group Inc.

Recruiting

APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (MAPLE-1)

Waldenstrom Macroglobulinemia

United States, China, Australia
Innovation Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Chronic Stable Plaque Psoriasis

United States
University of Michigan

Terminated

A Clinical Trial for CTD-ILD Treatment

Interstitial Lung Disease | Connective Tissue Disease

United States
Galapagos NV

Completed

A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis

Cystic Fibrosis

Spain, United Kingdom, United States, Netherlands, Belgium, Serbia
GlaxoSmithKline

Terminated

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

Systemic Lupus Erythematosus

Estonia, Germany, South Africa, Peru, Sweden, France, Korea, Republic of, Hong Kong, Spain, Romania, Czechia, Argentina, Chile, Hungary, Greece, Poland
Merck Sharp & Dohme LLC

Completed

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Hepatitis C Virus Infection
University of Chicago
National Institute on Drug Abuse (NIDA); University of Minnesota

Completed

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

Tobacco Use Disorder | Gambling

United States
Children's Hospital Medical Center, Cincinnati

Active, not recruiting

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1 (NF1NAC)

Neurofibromatosis 1

United States
Kafrelsheikh University
Ain Shams University

Unknown

N-Acetyl-Cysteine for Treatment of AGA in Men

Androgenetic Alopecia

Egypt
University of Turin, Italy

Completed

Effects of N-acetylcysteine on Diabetic Foot Oxygenation

Foot Ulcer, Diabetic

Italy
Ardea Biosciences, Inc.

Completed

Naïve HIV POC Monotherapy Trial

HIV Infections

Germany, United Kingdom
Shire

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Healthy Volunteers

United States
Baylor Research Institute

Completed

Acute Renal Failure Post Liver Transplantation

Acute Renal Failure

United States
University of Minnesota
Minnesota Medical Foundation

Completed

Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents

Deliberate Self Harm

United States
Pontificia Universidad Catolica de Chile

Completed

Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy (PRUE)

Stomach Neoplasms

Chile
Northwestern University

Not yet recruiting

Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma

Glioma, Malignant | New Diagnosis Tumor
Spinifex Pharmaceuticals Pty Ltd
Syneos Health

Withdrawn

Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN

Neuralgia, Postherpetic

Search clinical trials for: N-acetylcysteine (NAC) 600 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations